» Articles » PMID: 38356886

Distribution of the Hexanucleotide Repeat Expansion in Healthy Subjects: a Multicenter Study Promoted by the Italian IRCCS Network of Neuroscience and Neurorehabilitation

Abstract

Introduction: High repeat expansion (HRE) alleles in have been linked to both amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD); ranges for intermediate allelic expansions have not been defined yet, and clinical interpretation of molecular data lacks a defined genotype-phenotype association. In this study, we provide results from a large multicenter epidemiological study reporting the distribution of repeats in healthy elderly from the Italian population.

Methods: A total of 967 samples were collected from neurologically evaluated healthy individuals over 70 years of age in the 13 institutes participating in the RIN (IRCCS Network of Neuroscience and Neurorehabilitation) based in Italy. All samples were genotyped using the AmplideXPCR/CE Kit (Asuragen, Inc.), using standardized protocols that have been validated through blind proficiency testing.

Results: All samples carried hexanucleotide GC expansion alleles in the normal range. All samples were characterized by alleles with less than 25 repeats. In particular, 93.7% of samples showed a number of repeats ≤10, 99.9% ≤20 repeats, and 100% ≤25 repeats.

Conclusion: This study describes the distribution of hexanucleotide GC expansion alleles in an Italian healthy population, providing a definition of alleles associated with the neurological healthy phenotype. Moreover, this study provides an effective model of federation between institutes, highlighting the importance of sharing genomic data and standardizing analysis techniques, promoting translational research. Data derived from the study may improve genetic counseling and future studies on ALS/FTD.

Citing Articles

AI-Powered Neurogenetics: Supporting Patient's Evaluation with Chatbot.

Zampatti S, Farro J, Peconi C, Cascella R, Strafella C, Calvino G Genes (Basel). 2025; 16(1).

PMID: 39858576 PMC: 11765031. DOI: 10.3390/genes16010029.


Federated Learning: Breaking Down Barriers in Global Genomic Research.

Calvino G, Peconi C, Strafella C, Trastulli G, Megalizzi D, Andreucci S Genes (Basel). 2025; 15(12.

PMID: 39766917 PMC: 11728131. DOI: 10.3390/genes15121650.


Deciphering the Complexity of FSHD: A Multimodal Approach as a Model for Rare Disorders.

Megalizzi D, Trastulli G, Colantoni L, Proietti Piorgo E, Primiano G, Sancricca C Int J Mol Sci. 2024; 25(20).

PMID: 39456731 PMC: 11507453. DOI: 10.3390/ijms252010949.


Mutational Landscape of Alzheimer's Disease and Frontotemporal Dementia: Regional Variances in Northern, Central, and Southern Italy.

Saraceno C, Pagano L, Lagana V, Geviti A, Bagnoli S, Ingannato A Int J Mol Sci. 2024; 25(13).

PMID: 39000146 PMC: 11241147. DOI: 10.3390/ijms25137035.

References
1.
Hostettler I, Bernal-Quiros M, Wong A, Sharma N, Wilson D, Seiffge D . C9orf72 and intracerebral hemorrhage. Neurobiol Aging. 2019; 84:237.e1-237.e3. DOI: 10.1016/j.neurobiolaging.2019.07.007. View

2.
Kaivola K, Kiviharju A, Jansson L, Rantalainen V, Eriksson J, Strandberg T . C9orf72 hexanucleotide repeat length in older population: normal variation and effects on cognition. Neurobiol Aging. 2019; 84:242.e7-242.e12. PMC: 8981799. DOI: 10.1016/j.neurobiolaging.2019.02.026. View

3.
Iacoangeli A, Al Khleifat A, Jones A, Sproviero W, Shatunov A, Opie-Martin S . C9orf72 intermediate expansions of 24-30 repeats are associated with ALS. Acta Neuropathol Commun. 2019; 7(1):115. PMC: 6637621. DOI: 10.1186/s40478-019-0724-4. View

4.
Al Khleifat A, Iacoangeli A, van Vugt J, Bowles H, Moisse M, Zwamborn R . Structural variation analysis of 6,500 whole genome sequences in amyotrophic lateral sclerosis. NPJ Genom Med. 2022; 7(1):8. PMC: 8799638. DOI: 10.1038/s41525-021-00267-9. View

5.
Gijselinck I, Van Mossevelde S, van der Zee J, Sieben A, Engelborghs S, De Bleecker J . The C9orf72 repeat size correlates with onset age of disease, DNA methylation and transcriptional downregulation of the promoter. Mol Psychiatry. 2015; 21(8):1112-24. PMC: 4960451. DOI: 10.1038/mp.2015.159. View